Biontech bntx stock
WebApr 10, 2024 · 0. 0. In the last 3 months, 12 analysts have offered 12-month price targets for BioNTech. The company has an average price target of $169.33 with a high of $216.00 and a low of $128.00. Below is a ... WebApr 7, 2024 · Fintel reports that on April 10, 2024, JP Morgan maintained coverage of BioNTech SE (NASDAQ:BNTX) with a Neutral recommendation. As of April 7, 2024, the …
Biontech bntx stock
Did you know?
WebMar 28, 2024 · Overview. Zacks Rank #5 (Strong Sell) stock BioNTech ((BNTX Quick Quote BNTX - Free Report) ) is a German biotech firm that develops and commercializes immunotherapies and innovative cancer ... WebBNTX Stock 12 Months Forecast. $173.70. (34.76% Upside) Based on 11 Wall Street analysts offering 12 month price targets for BioNTech SE in the last 3 months. The …
WebSep 30, 2024 · But top COVID-19 vaccine-makers Moderna ( MRNA -1.16%), BioNTech ( BNTX -1.76%), and Novavax ( NVAX -0.34%) saw their shares tank this week despite either announcing a positive development or...
WebApr 12, 2024 · BioNTech Stock Performance. NASDAQ:BNTX opened at $126.34 on Monday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 7.28 and a … WebNov 7, 2024 · On the stock market today, BNTX stock advanced 4.2% to 160.72. That pared from much deeper, double-digit declines in premarket trading. BNTX Stock: Booster Demand Is Key As of...
WebBioNTech SE (NASDAQ:BNTX) 128.92. Delayed Data. As of Apr 06. +3.32 / +2.64%. Today’s Change. 117.08. Today 52-Week Range. 188.99.
WebFounded. 2008. BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, … commercial scaffolding norwichWebApr 10, 2024 · BioNTech (NASDAQ: BNTX) got a substantial boost from the pandemic and its mRNA vaccine, developed with Pfizer (NYSE: PFE). The stock has seen a … commercial scaffolding services readingWebApr 8, 2024 · Systrade AG bought a new stake in BioNTech SE (NASDAQ:BNTX - Get Rating) during the fourth quarter, according to its most recent disclosure with the … commercial scheduleWebMar 2, 2024 · Biopharmaceutical New Technologies or BioNTech ( NASDAQ: BNTX) is a large ($31 billion market cap) immunotherapy company. They are developing cancer product candidates (Figure 1) but known mostly ... commercial schedule of conditionWebMar 28, 2024 · Bear of the Day: BioNTech (BNTX) Andrew Rocco March 28, 2024, 4:00 AM · 2 min read Overview Zacks Rank #5 (Strong Sell) stock BioNTech ( BNTX) is a German biotech firm that develops and... commercials castWebApr 10, 2024 · 0. 3. 0. 0. In the last 3 months, 12 analysts have offered 12-month price targets for BioNTech. The company has an average price target of $169.33 with a high of $216.00 and a low of $128.00 ... commercial scary pop upWebApr 11, 2024 · According to the issued ratings of 13 analysts in the last year, the consensus rating for BioNTech stock is Hold based on the current 7 hold ratings and 6 buy ratings for BNTX. The average twelve-month price prediction for BioNTech is $178.50 with a high price target of $260.00 and a low price target of $130.00. dss and bs3 crosslinkers